Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing tags : Therapeutics save search
Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
VIRX | $0.909 -2.91% -4.36% 79K
|
Manufacturing
|
| O: -12.71%
H: 0.97%
C: -24.27%
t-cell positive topline trial therapeutics results
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
PPRUF | News | $358.55 -0.93% 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.13%
H: 0.52%
C: 0.47%
PPRUY | News | $36.0023 -0.08% -0.11% 220K
|
Manufacturing
|
| O: 0.39%
H: 0.0%
C: -0.23%
ELYM | $4.18 -5.64% -3.99% 200K
|
|
| O: 49.44%
H: 0.0%
C: 0.0%
million acquire therapeutics agreement
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
CYTO | $1.5 1.35% -7.95% 25K
|
Manufacturing
|
| O: -5.56%
H: 7.49%
C: 6.95%
business year therapeutics financial results
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-04-09 (Crawled : 12:30) - globenewswire.com
LSTA | $2.85 2.52% -5.82% 1.1K
|
Manufacturing
|
| O: 0.34%
H: 9.62%
C: 3.78%
fda drug granted treatment designation for therapeutics
AffyImmune Therapeutics Announces Clinical and Regulatory Advisory Board to Support Development of AIC100 in Solid Tumors
Published: 2024-04-08 (Crawled : 13:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
aic100 tumors therapeutics
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
CYTO | $1.5 1.35% -7.95% 25K
|
Manufacturing
|
| O: 4.21%
H: 5.56%
C: 5.56%
business year update therapeutics financial results
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Published: 2024-04-04 (Crawled : 11:00) - globenewswire.com
ACHL | $0.8 -1.78% -2.45% 190K
|
Manufacturing
|
| O: -16.22%
H: 0.99%
C: -7.89%
business therapeutics financial results
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
ACHL | $0.8 -1.78% -2.45% 190K
|
Manufacturing
|
| O: -16.22%
H: 0.99%
C: -7.89%
first melanoma update therapeutics advanced
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
LSTA | $2.85 2.52% -5.82% 1.1K
|
Manufacturing
|
| O: 0.65%
H: 0.0%
C: -1.94%
therapeutics
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
AVTX | $12.01 -11.82% -11.37% 100K
|
Manufacturing
|
| O: -22.8%
H: 15.52%
C: 1.07%
ICLR | $291.82 -0.07% -0.1% 500K
|
Health Technology
|
| O: -2.95%
H: 0.0%
C: -1.43%
BIIB | $190.52 -0.85% -0.84% 1.3M
|
Health Technology
|
| O: -1.11%
H: 0.16%
C: -2.56%
biotech leaders therapeutics
Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
VIRX | $0.909 -2.91% -4.36% 79K
|
Manufacturing
|
| O: 0.96%
H: 8.57%
C: 5.71%
congress topline trial therapeutics results
Edgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
EWTX | $15.45 -1.28% -1.43% 530K
|
Manufacturing
|
| O: 1.4%
H: 4.14%
C: 3.34%
symposium therapeutics
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
ATXS | $10.54 -0.1% 0.09% 320K
|
Manufacturing
|
| O: 10.71%
H: 0.9%
C: -11.94%
star-0215 positive trial therapeutics results
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
CYTO | $1.5 1.35% -7.95% 25K
|
Manufacturing
|
| O: 83.24%
H: 10.09%
C: -25.87%
mrna group collaboration therapeutics
LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
VIRX | $0.909 -2.91% -4.36% 79K
|
Manufacturing
|
| O: 0.88%
H: 2.63%
C: -6.14%
update therapeutics
Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
LSTA | $2.85 2.52% -5.82% 1.1K
|
Manufacturing
|
| O: 0.32%
H: 9.68%
C: 8.06%
fda rare disease granted treatment designation therapeutics
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | $0.2595 29.69% 37.35% 720
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.0015 -6.25% 14185.71% 640
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | $60.07 0.1% 0.11% 2M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $3.06 0.99% -3.56% 930
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
cmc therapeutics
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
Published: 2024-03-18 (Crawled : 12:30) - prnewswire.com
NRXP 1 d | $3.02 -27.75% -38.18% 760K
|
Manufacturing
|
| O: 2.5%
H: 22.19%
C: 10.4%
sales ketamine hope pharmaceuticals royalty therapeutics
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
PPRUF | News | $358.55 -0.93% 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.49%
H: 2.65%
C: 2.65%
PPRUY | News | $36.0023 -0.08% -0.11% 220K
|
Manufacturing
|
| O: -0.43%
H: 0.02%
C: -0.5%
PHGE | News | $0.2958 5.61% -14.06% 110K
|
Health Technology
|
| O: 1.09%
H: 3.38%
C: -2.7%
million acquisition therapeutics
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.